ZEB2 and prostate carcinoma: Also, ZEB1 expression was associated with prostate cancer (PCa) progression and metastasis (Putzke et al., 2011), while Twist1 plus ZEB2 expression was related to early disease recurrence in HCC (Yamada et al., 2014).